Gen-Wealth Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Gen-Wealth Partners's MRNA Position: Q3 2026 in Review
Gen-Wealth Partners held its Moderna (MRNA) position steady in Q3 2026 at 10 shares worth $1.93K. The position accounts for ﹤0.01% of the portfolio, ranked #692.
Gen-Wealth Partners first reported a position in MRNA in Q1 2024 and has held it in 11 quarters since. The position peaked at $2.97K in Q2 2024. 1,053 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Gen-Wealth Partners held 10 shares of Moderna worth $1.93K as of Q3 2026.
- Gen-Wealth Partners left its Moderna share count unchanged in Q3 2026.
- Moderna made up ﹤0.01% of Gen-Wealth Partners's portfolio in Q3 2026, its #692 holding.
- Gen-Wealth Partners first reported a position in Moderna in Q1 2024 and has held it in 11 quarters since.
- Gen-Wealth Partners's Moderna position peaked at $2.97K in Q2 2024.
- 1,053 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Gen-Wealth Partners's 13F filing for Q3 2026, filed 4 Nov 2026.